Laroche Geneviève, Rochdi Moulay Driss, Laporte Stéphane A, Parent Jean-Luc
Service de Rhumatologie, Département de Médecine, Faculté de Médecine and Centre de Recherche Clinique, Université de Sherbrooke, Quebec, Canada.
J Biol Chem. 2005 Jun 17;280(24):23215-24. doi: 10.1074/jbc.M414071200. Epub 2005 Apr 20.
The role of actin in endocytosis of G protein-coupled receptors is poorly defined. In the present study, we demonstrate that agents that depolymerize (latrunculin B and cytochalasin D) or stabilize (jasplakinolide) the actin cytoskeleton blocked agonist-induced endocytosis of the beta isoform of the thromboxane A(2) receptor (TPbeta) in HEK293 cells. This suggests that endocytosis of TPbeta requires active remodeling of the actin cytoskeleton. On the other hand, disruption of microtubules with colchicine did not affect endocytosis of the receptor. Expression of wild-type and mutant forms of the small GTPases RhoA and Cdc42 potently inhibited endocytosis of TPbeta, further indicating a role for the dynamic regulation of the actin cytoskeleton in this pathway. Agonist treatment of TPbeta in HEK293 cells resulted in the formation of actin stress fibers through Galpha(q/11) signaling. Because we previously showed that endocytosis of TPbeta is dependent on arrestins, we decided to explore the relation between arrestin-2 and -3 and actin in endocytosis of this receptor. Interestingly, we show that the inhibition of TPbeta endocytosis by the actin toxins in HEK293 cells was overcome by the overexpression of arrestin-3, but not of arrestin-2. These results indicate that the actin cytoskeleton is not essential in arrestin-3-mediated endocytosis of TPbeta. However, arrestin-3 could not promote endocytosis of the TPbetaY339A and TPbetaI343A carboxyl-terminal mutants when the actin cytoskeleton was disrupted. Our data provide new evidence that the actin cytoskeleton plays an essential role in TPbeta endocytosis. Furthermore, our work suggests the existence of actin-dependent and -independent arrestin-mediated pathways of endocytosis.
肌动蛋白在G蛋白偶联受体的内吞作用中的作用尚不明确。在本研究中,我们证明,使肌动蛋白细胞骨架解聚的试剂(拉春库林B和细胞松弛素D)或使其稳定的试剂(茉莉素)会阻断激动剂诱导的血栓素A2受体(TPβ)β亚型在HEK293细胞中的内吞作用。这表明TPβ的内吞作用需要肌动蛋白细胞骨架的主动重塑。另一方面,用秋水仙碱破坏微管并不影响该受体的内吞作用。小GTP酶RhoA和Cdc42的野生型和突变型的表达强烈抑制了TPβ的内吞作用,进一步表明肌动蛋白细胞骨架的动态调节在该途径中发挥作用。在HEK293细胞中用激动剂处理TPβ会通过Gαq/11信号传导导致肌动蛋白应力纤维的形成。因为我们之前表明TPβ的内吞作用依赖于抑制蛋白,所以我们决定探究抑制蛋白-2和-3与该受体内吞作用中的肌动蛋白之间的关系。有趣的是,我们发现,在HEK293细胞中,肌动蛋白毒素对TPβ内吞作用的抑制可被抑制蛋白-3的过表达克服,但不能被抑制蛋白-2的过表达克服。这些结果表明,肌动蛋白细胞骨架在抑制蛋白-3介导的TPβ内吞作用中并非必不可少。然而,当肌动蛋白细胞骨架被破坏时,抑制蛋白-3不能促进TPβY339A和TPβI343A羧基末端突变体的内吞作用。我们的数据提供了新的证据,证明肌动蛋白细胞骨架在TPβ内吞作用中起重要作用。此外,我们的工作表明存在肌动蛋白依赖性和非依赖性的抑制蛋白介导的内吞途径。